The lights
Abreu et al. 1 showed that cardiac rehabilitation is available in 39 of the 44 (88.6%) European countries involved in the survey, thus a very high proportion of countries offers cardiac rehabilitation programmes to their citizens. Encouraging findings also are the consistency of programme delivery of European cardiac rehabilitation guidelines, with a median of 17 h of cardiac rehabilitation prescribed per patient, 6.5 staff members and 8.5 of 11 core components offered per programme, on average.
Moreover, the present survey regards a larger sample of countries than did the previous one. 2 It is also important to note that, regarding programme volumes, staff members and core-components, Europe showed a more favourable profile than other, non-European, high-income countries.
Finally, the indications for cardiac rehabilitation were uniformly distributed among the different European areas, with heart failure less often present in Southern Europe countries. In comparison with non-European high-income countries, no significant differences were present in indications to cardiac rehabilitation with the exception of valve procedures, significantly more often accepted in Europe.
The shadows
A very important finding of the paper of Abreu et al. 1 is the estimate of the unmet need for cardiac rehabilitation in Europe. Concerning ischaemic heart disease, overall European density of cardiac rehabilitation was, on average, one spot per seven patients/year per country, with a strong discrepancy based on continental area. Density was one spot per two for Northern, per four for Western, per 13 for Southern and per 21 patients/year per country for the Eastern Region. Data suggest that over three million more spots are needed per year only to treat patients with ischaemic heart disease, not considering other consolidated indications for cardiac rehabilitation, such as heart failure, and new emerging indications such as transcatheter aortic valve replacement. 3 Another major point concerns payment for cardiac rehabilitation programmes. Abreu et al. 1 found that government is the most common funding source for cardiac rehabilitation programmes; nevertheless approximately 40% of programme costs are paid outof-pocket by patients. These data strongly suggest that government policies should include advocacy for a larger reimbursement of cardiac rehabilitation services by public and private healthcare insurance in order to reduce the impact of costs on the patients.
Finally, 33.5% of programmes reported availability of cardiac rehabilitation alternative models such as home-based, electronic and community-based cardiac rehabilitation. Only 21% of programmes that offered alternative models (5.5% of all programmes) reported tools attributable to a form of electronic cardiac rehabilitation, such as the use of smartphones, 'apps' or text-messaging by the patients. Data of the present survey suggest that cardiac rehabilitation alternative models should be expanded since multiple behaviours and cardiovascular disease risk factors appear modifiable in the shorter term with use of mobile applications. 4 Where we are going
The paper by Abreu et al. 1 gives us very important information about the actual unmet needs of cardiac rehabilitation in Europe, providing also significant data about the organization of cardiac rehabilitation services and funding politics in different European countries.
However, as the authors themselves point out, the paper does not ascertain whether and how cardiac rehabilitation programmes and process indicators affect patient outcome, nor the content and the 'dose' of each core component. These are crucial points and reinforcement and development of an already existing European registry 5 is necessary to evaluate quality of cardiac rehabilitation programmes, allowing the scientific community the identification of indicators useful in benchmarking politics.
Therefore, acquiring data at the patient-level is necessary. If the present survey shows that programme delivery seems to be consistent with European cardiac rehabilitation guidelines, data from a previous study, regarding 2.054 cardiac rehabilitation patients in 12 European countries, showed a different conclusion, with discrepancies in patient clinical characteristics, indications and programmes with a poor adherence to guidelines. 5 Benzer et al. 5 suggested that patient selection and cardiac rehabilitation programmes should become more evidence-based. This is true also in exercise training modalities, an indisputable pillar of cardiac rehabilitation interventions. Despite advances in cardiac rehabilitation, there is still a significant need for improvement of functional evaluation and exercise training prescription, also by the use of decision support algorithms such as the EXPERT tool. 6, 7 Cardiac rehabilitation is a fundamental step in the field of secondary prevention. Nevertheless, data at the patient-level are necessary because increase in life expectancy and continuous evolution of cardiovascular medicine have substantially changed the epidemiological picture of cardiovascular diseases, with an increase in the prevalence of chronic conditions characterized by multimorbidity, associated with frailty and disability, such as heart failure. 8 Although morbidity and mortality still occur during hospitalization, the substantial majority of events occur after patients with heart failure leave the hospital, in the immediate post-discharge period, the so-called vulnerable phase. 9 Phase-2 cardiac rehabilitation, especially in the residential setting, may be particularly well suited to managing patients with still unstable heart failure and at high risk of early rehospitalization after an acutecare stay, that is, to playing the role of 'transitional care'. 10 Current standard medicine (based on evidence) is based, when possible, on randomized controlled clinical trials. The results are often generalized and become prescriptive. In reality, each person has their own unique genotype and phenotype and any 'generalizable' knowledge has limits. The best that can be done today is 'individualized medicine', while the type of medicine we are trying to build, hence our objective, is 'precision medicine'. In a recent document, a concrete and prospective picture of precision medicine is outlined.
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It proposes a comprehensive and interactive model of current technological and intellectual forces, and is aimed at research and clinical practice. It is schematically shown in Figure 1 . Cardiac rehabilitation could adapt itself more or less to this scheme, portraying an image of itself as an open medical area, well-educated, sufficiently technologized to provide aetiopathogenetic insights, able to accompany patients with a participatory and highly professional approach, offering continuous availability over time, combined with the confidence to obtain what medicine can give. In the United States, large collaborative networks are already moving along these lines. The Million Hearts Cardiac Rehabilitation Collaborative aims to have 70% of eligible cardiac rehabilitation candidates participate in cardiac rehabilitation programmes by 2022, and estimates the prevention of 25,000 deaths and 180,000 hospitalizations per year. 12 An ambitious result, but highly necessary also in Europe.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
